Rinvoq ER 45 MG tablet UU 28S
Ended Awarded Last action
- Contract number
- SPE2DR26F9NZ0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,917
Award facts
- Contract value 100% obligated
- $72,916.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $72,916.74 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 45 mg tablets (28-count units). This firm fixed-price, competitively awarded contract carries an ultimate completion date of February 3, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The award was issued with no set-aside designation, indicating full and open competition among qualified vendors.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 2031. As a critical pharmaceutical distributor for federal medical procurement, Cencora supplies a comprehensive range of prescription medications, medical devices, and healthcare commodities to military healthcare systems and other government agencies worldwide. RINVOQ (upadacitinib) is a JAK inhibitor used in the treatment of rheumatoid arthritis and other inflammatory conditions, reflecting the company's role in delivering specialized pharmaceuticals to support military and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F9NZ0?
SPE2DR26F9NZ0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26F9NZ0 worth?
The government has obligated $72,917 on SPE2DR26F9NZ0.
Is contract SPE2DR26F9NZ0 an order under another contract?
Yes. SPE2DR26F9NZ0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NZ0 competed?
The extent of competition for SPE2DR26F9NZ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award